Neuraly
A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease.
1
Funding Rounds
$36.0m
Money raised
Overview
A biotech company using technology created at Johns Hopkins School of Medicine for the development of neuroprotective agents for neurologic disorders like Alzheimer’s disease and Parkinson’s disease.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ma**** Po**** | - | - | - |
| Te* Da**** | - | - | - |
| Ha* Se** Ko | - | - | - |
Funding series
Funding Series Analysis
The company Neuraly has raised a total of $36m in funding over 1 rounds.
Key Insights:
- Neuraly Series A round, July 2018: $36m
Neuraly Series A round, July 2018
$36m
Industries
Neuraly is active in the following industries: